Medicina Interna, Dermatología y Psiquiatría
Departamento
Hospital Universitario Virgen Macarena
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen Macarena (63)
2024
-
Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023
Neurologia, Vol. 39, Núm. 2, pp. 196-208
-
Real-world persistence of initial targeted therapy strategy in monotherapy versus combination therapy in patients with chronic inflammatory arthritis
European Journal of Clinical Investigation, Vol. 54, Núm. 2
2023
-
A genetic profiling guideline to support diagnosis and clinical management of lymphomas
Clinical and Translational Oncology
-
Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study
RMD open, Vol. 9, Núm. 1
-
Juvenile idiopathic arthritis in the young adult. Methodology, objectives, and initial data from the JUVENSER registry
Reumatologia Clinica, Vol. 19, Núm. 6, pp. 328-333
-
Overlapping versus single long stents in long chronic total occlusions: insights of the Iberian CTO Registry
Minerva cardiology and angiology, Vol. 71, Núm. 3, pp. 284-293
-
Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain
Annals of Hematology, Vol. 102, Núm. 2, pp. 447-456
-
SEOM-GOTEL clinical guidelines on diffuse large B cell lymphoma (2022)
Clinical and Translational Oncology, Vol. 25, Núm. 9, pp. 2749-2758
-
Spanish cardiac catheterization and coronary intervention registry. 32nd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2022)
Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1021-1031
-
Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors
Cancers, Vol. 15, Núm. 4
-
What drives the decision to optimise biological treatment in children and youngsters with juvenile idiopathic arthritis? A discrete-choice experiment
Reumatologia Clinica, Vol. 19, Núm. 1, pp. 26-33
2022
-
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
Neurologia, Vol. 37, Núm. 8, pp. 615-630
-
Expert-Agreed Practical Recommendations on the Use of Cladribine
Neurology and Therapy
-
Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia
Annals of Hematology, Vol. 101, Núm. 10, pp. 2263-2270
2021
-
Changes in the use patterns of bDMARDs in patients with rheumatic diseases over the past 13 years
Scientific Reports, Vol. 11, Núm. 1
-
Consulta monográfica de onconefrología. Justificación y puesta en marcha
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 41, Núm. 2, pp. 154-164
-
Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation
BMC Cardiovascular Disorders, Vol. 21, Núm. 1
-
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study
The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792
-
Management of Psoriasis During Preconception, Pregnancy, Postpartum, and Breastfeeding: A Consensus Statement
Actas Dermo-Sifiliograficas, Vol. 112, Núm. 3, pp. 225-241
-
Predictors of clinically significant quality of life impairment in Parkinson’s disease
npj Parkinson's Disease, Vol. 7, Núm. 1